The maker of a commonly used drug treatment for people with multiple sclerosis says it will cover the hospitalization costs of any Health Alliance Medical Plan member who sticks to the treatment regimen and has a severe relapse

Stuart SchlossmanMisc. MS Related, MS Drug Therapies, Multiple Sclerosis

December 8, 2011

The drug company, Bayer HealthCare, said its agreement with Health Alliance in Urbana represents the first time it has entered into such a contract with an insurer.
Bayer is the maker of Betaseron, an injectable drug intended for patients with relapsing-remitting multiple sclerosis, the most common form of MS, an autoimmune disease affecting the central nervous system.
Betaseron, a brand name for interferon beta-1B, is intended to reduce the frequency of relapses.
An average hospitalization for an MS patient with a severe relapse runs $12,000, the company said.
Bayer offers a program to help patients get started and remain on the medication, and said its agreement with Health Alliance reinforces its belief that when patients stick to the treatment plan, their chances for a better clinical outcome improve.
About 400,000 people in the U.S. have MS, and about 75 to 85 percent of everyone with the disease is initially diagnosed with relapsing-remitting MS, according to the National Multiple Sclerosis Society.
Dr. Robert Parker, Health Alliance’s chief medical officer, said this isn’t the first time Health Alliance has sought an agreement with a drug company to stand behind the success of a costly treatment for its members.
Health Alliance formerly had a similar agreement with the maker of an osteoporosis drug, he said.
Members are assumed to be complying with treatment as prescribed if Health Alliance is receiving regular pharmacy claims for the medication, Parker said.
Bayer spokeswoman JoAnne Marlin said Bayer is in discussions with other insurers to negotiate similar agreements.
Source: News-Gazette





..Comments for each blog posting are always appreciated. 

     Please use the comment link found below..
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
 – Click to: REGISTER – For our MS weekly e-Newsletter

Providing You with ‘MS Views and News’, IS What We Do”   ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
Help us to educate $ DONATE NOW PLEASE $

“MS Views and News”  is a 501©(3) Not-For-Profit organization
 as recognized by the Internal Revenue Service

All contributions are tax deductible to the fullest extent allowed by law
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Disclaimer:  ‘MS Views and News’ (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

…………………………
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews